市场调查报告书
商品编码
1547994
全球合法大麻市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测Global Legal Marijuana Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球合法大麻市场需求预计将从 2023 年的 207.8 亿美元达到近 1,499.9 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 24.56%。
一些国家已将出于医疗和娱乐目的持有、分配、种植和消费大麻合法化。而且,在大多数国家,这些政策均受《联合国麻醉药品单一公约》监管。大麻在市场上有多种形式:花蕾、油和酊剂。这种精神活性药物的医学应用会导致慢性疼痛、精神障碍、癌症和其他神经系统疾病。大麻的成人用途包括用作食品成分和精神药物。
随着医疗和成人用途的合法大麻使用量激增,全球对其的需求预计将大幅增加。此外,对疼痛管理治疗的需求不断增长,加上老年族群慢性疼痛负担的增加,预计将提高产品需求。然而,COVID-19大流行对消费者的购买能力和无缝贸易施加了一些限制。这是合法大麻市场面临的主要挑战。另一方面,大麻在治疗多种疾病、癌症、焦虑症、帕金森氏症和阿兹海默症方面的应用范围预计将预示着产品在全球市场的渗透。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球合法大麻市场的每个细分市场进行了包容性评估。合法大麻产业的成长和趋势为本研究提供了整体方法。
合法大麻市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲合法大麻市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。合法大麻市场的主要参与者包括顶篷 Growth Corporation、Aurora Cannabis Inc.、Tilray Brands Inc. (Aphria Inc.)、Abcann Medicinals Inc. (Vivo Cannabis Inc.)、The Cronos Group、Maricann Inc.、 Organigram Holdings Inc. .、Lexaria Bioscience、Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.)、Tikun Olam、United Cannabis Corporation。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Legal Marijuana Market is presumed to reach the market size of nearly USD 149.99 Billion by 2032 from USD 20.78 Billion in 2023 with a CAGR of 24.56% under the study period 2024-2032.
Several countries have legalized possession, distribution, cultivation, and consumption of marijuana for medical and recreational purposes. And, in most nations, these policies are regulated by the United Nations Single Convention on Narcotic Drugs. Marijuana is available in several forms in the market, buds, oil, and tinctures. The medical application of this psychoactive drug is subjected to chronic pain, mental disorders, cancer, and other neurological diseases. The Adult-use of marijuana can range from being used as a food ingredient to a psychoactive drug.
With the soar in the use of legal marijuana for medical and adult-use, the global demands for the same are anticipated to grow significantly. Moreover, the growing need for pain management treatments along with the rising burden of chronic pain among the geriatric population is anticipated to lift the product demand. However, the COVID-19 pandemic has imposed several restrictions in terms of the buying capability of consumers and seamless trade. This acts as a key challenge for the legal marijuana market. On the other side, the scope of marijuana in treating several ailments, cancer, anxiety, and Parkinson's and Alzheimer's disease is anticipated to bode well for product penetration in the global market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Legal Marijuana. The growth and trends of Legal Marijuana industry provide a holistic approach to this study.
This section of the Legal Marijuana market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Legal Marijuana market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Legal Marijuana market include Canopy Growth Corporation, Aurora Cannabis Inc., Tilray Brands Inc. (Aphria Inc.), Abcann Medicinals Inc. (Vivo Cannabis Inc.), The Cronos Group, Maricann Inc., Organigram Holdings Inc., Lexaria Bioscience, Gw Pharmaceuticals (Jazz Pharmaceuticals Inc.), Tikun Olam, United Cannabis Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.